BB

Bhushanrao Bhagawan Jadhav

Active Director Director DIN 09328518
DIN 09328518 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhushanrao Bhagawan Jadhav

Data last updated:

Bhushanrao Bhagawan Jadhav is a Director at Reya Plus Pharma Private Limited (since 2021). The company operates in Pharma.

DIN 09328518
Primary Designation Director
Industry Pharma
First Appointment 22 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Reya Plus Pharma Private Limited U51909MH2021PTC367912
Director22 Sep 20212021Active

Board colleagues of Bhushanrao Bhagawan Jadhav

NameDINCompanyDesignation
Gautami Hemant Shinde09328519Reya Plus Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Reya Plus Pharma Private Limited
Premium access

Shareholding and investment profile for Bhushanrao Bhagawan Jadhav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhushanrao Bhagawan Jadhav

Bhushanrao Bhagawan Jadhav currently holds 1 directorship: Reya Plus Pharma Private Limited (Director, since 22 Sep 2021).

Bhushanrao Bhagawan Jadhav was first appointed on 22 Sep 2021 as Director at Reya Plus Pharma Private Limited.

The current boards of Bhushanrao Bhagawan Jadhav's companies include Gautami Hemant Shinde (Reya Plus Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available